GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » AlzChem Group AG (XTER:ACT) » Definitions » Asset Impairment Charge

AlzChem Group AG (XTER:ACT) Asset Impairment Charge : €0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is AlzChem Group AG Asset Impairment Charge?

AlzChem Group AG's Asset Impairment Charge for the three months ended in Mar. 2024 was €0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was €0.0 Mil.


AlzChem Group AG Asset Impairment Charge Historical Data

The historical data trend for AlzChem Group AG's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AlzChem Group AG Asset Impairment Charge Chart

AlzChem Group AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AlzChem Group AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AlzChem Group AG Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.


AlzChem Group AG Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of AlzChem Group AG's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


AlzChem Group AG (XTER:ACT) Business Description

Traded in Other Exchanges
Address
Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308
AlzChem Group AG is an international chemical company. Its reportable segments are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from Germany.

AlzChem Group AG (XTER:ACT) Headlines

From GuruFocus

Enact to Host Fourth Quarter 2022 Earnings Call February 7th

By GlobeNewswire GlobeNewswire 01-06-2023

Enact Enters Into $200 Million Revolving Credit Facility

By GuruFocusNews GuruFocusNews 07-07-2022

Enact to Host Fourth Quarter 2022 Earnings Call February 7th

By Stock market mentor Stock market mentor 01-06-2023

Enact To Participate at the Bank of America 2023 Financial Services Conference

By Stock market mentor Stock market mentor 02-03-2023

Enact to Host Second Quarter 2022 Earnings Call August 2nd

By GuruFocusNews GuruFocusNews 07-08-2022

Enact Receives Ratings Upgrade from Fitch Ratings

By sperokesalga sperokesalga 04-25-2023